Search research articles
Contact Us
Filters
Showing results (431-440 of 458) with videos related to
Page
of 46
Sort By:
Lancet (London, England)
|
January 28, 2025
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
Thierry André, Elena Elez, Heinz-Josef Lenz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2017
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database
Lindsay A Renfro, Richard M Goldberg, Axel Grothey, et al.
JAMA Network Open
|
September 21, 2019
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer
Tomasz Burzykowski, Elisabeth Coart, Everardo D Saad, et al.
Journal of the National Cancer Institute
|
August 18, 2021
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database
Zhaohui Jin, Jesse G Dixon, Jack M Fiskum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2017
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Milind Javle, Maeve Lowery, Rachna T Shroff, et al.
Therapeutic Advances in Medical Oncology
|
July 15, 2021
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis
Jun Yin, Shaheenah Dawood, Romain Cohen, et al.
The New England Journal of Medicine
|
September 9, 2020
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis
Carol A Burke, Evelien Dekker, Patrick Lynch, et al.
JNCI Cancer Spectrum
|
May 23, 2022
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials
Nadine J McCleary, William S Harmsen, Ellana Haakenstad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2022
Adjuvant <i>nab</i>-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly, et al.
ESMO Open
|
August 30, 2017
Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)
Riccardo Ricotta, Antonella Verrioli, Silvia Ghezzi, et al.
Page
of 46
Search research articles
Search
Showing results (431-440 of 458) with videos related to
Sort By:
Page
of 46
Lancet (London, England)
|
January 28, 2025
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
Thierry André, Elena Elez, Heinz-Josef Lenz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2017
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database
Lindsay A Renfro, Richard M Goldberg, Axel Grothey, et al.
JAMA Network Open
|
September 21, 2019
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer
Tomasz Burzykowski, Elisabeth Coart, Everardo D Saad, et al.
Journal of the National Cancer Institute
|
August 18, 2021
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database
Zhaohui Jin, Jesse G Dixon, Jack M Fiskum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2017
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Milind Javle, Maeve Lowery, Rachna T Shroff, et al.
Therapeutic Advances in Medical Oncology
|
July 15, 2021
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis
Jun Yin, Shaheenah Dawood, Romain Cohen, et al.
The New England Journal of Medicine
|
September 9, 2020
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis
Carol A Burke, Evelien Dekker, Patrick Lynch, et al.
JNCI Cancer Spectrum
|
May 23, 2022
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials
Nadine J McCleary, William S Harmsen, Ellana Haakenstad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2022
Adjuvant <i>nab</i>-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly, et al.
ESMO Open
|
August 30, 2017
Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study)
Riccardo Ricotta, Antonella Verrioli, Silvia Ghezzi, et al.
Page
of 46